Shaping the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market in 2025: Innovative Inhalation Devices With Digital Health Features Driving The COPD And Asthma Devices Market

How Big Is the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been a substantial surge in the market size for chronic obstructive pulmonary disease (COPD) and asthma devices. The market value is expected to jump from $44.95 billion in 2024 to approximately $47.83 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors such as an upward trend in elderly populations, a rising number of allergy cases, government initiatives, amplified clinical research and trials, as well as booming urbanization have propelled the growth during the historical timeline.

In the coming years, substantial growth is anticipated for the chronic obstructive pulmonary disease (COPD) and asthma devices market. By 2029, it is predicted to expand to a value of $60.53 billion, with a 6.1% compound annual growth rate (CAGR). This ascending trajectory during the forecast period can be linked to an increase in respiratory illnesses, a surge in cigarette consumption, escalating levels of environmental pollution and breathing problems, an expanding incidence of respiratory ailments, increased healthcare spending, and enhanced portability of drug delivery devices. Key trends expected in this period involve technological advancements, the incorporation of smart technology, personalized healthcare, embracing biologics, and the use of wearable respiratory monitors.

What Factors Are Fueling Growth in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The increasing incidence of respiratory conditions is projected to fuel the expansion of the market for chronic obstructive pulmonary disease (COPD) and asthma devices. These diseases include a range of disorders impacting the lungs and respiratory systems, such as COPD, asthma, pneumonia, and lung cancer, all of which affect breathing and overall respiratory performance. The escalating occurrence of these diseases can be attributed to rising air pollution levels, shifting climate patterns impacting allergens and pathogens, and lifestyle choices like smoking that deteriorate respiratory health. Devices for COPD and asthma are crucial for the all-encompassing management and treatment of these respiratory conditions, aiding patients in attaining improved respiratory health and boosting their overall wellness. For example, in March 2023, the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations in charge of international public health, announced that COPD was the third largest cause of death worldwide, leading to approximately 3.23 million deaths. Moreover, nearly 90% of these deaths among individuals below 70 years of age took place in low and middle-income nations. Hence, the rising incidence of respiratory conditions propels the growth of the market for COPD and asthma devices.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp

Who Are the Dominant Companies Influencing Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Trends?
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

How Is the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Evolving?
Leading businesses in the COPD and asthma devices market are shifting their focus toward the creation of groundbreaking technologies such as inhalation devices they could integrate with digital health components for distant monitoring and customised treatment management. Inhalation devices are medical tools that deliver medication straight into the lungs via inhalation. For example, Alkem Laboratories, a pharmaceutical firm based in India, rolled out the Innohaler, a dry powder inhaler (DPI) apparatus, in May 2022, designed to improve the lives of asthma and COPD patients. The Innohaler embodies cutting-edge breath-actuated technology which confirms accurate drug delivery with each inhalation, enhancing dosage correctness and minimising waste. Its user-friendly interface accentuated by an ergonomic design simplifies operation for patients across all age groups. This compact, portable device ensures convenience, thus enhancing patient compliance with prescribed therapies.

What Are the Different Segmentations in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented -

1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric

Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-and-asthma-devices-global-market-report

Which Region Is at the Forefront of the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report?

- Market Size Analysis: Analyze the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18298

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.